Inactive Instrument
Sector Signal Genetics Inc Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-31 | Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push | RE |
| 08-07 | Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.97% | -0.75% | +4.14% | +17.53% | +8.48% | +3.51% | +17.79% | -24.92% | +211.15% | 49.74B | |
| -0.46% | -3.27% | +14.22% | +37.73% | +161.64% | +427.18% | +518.57% | +598.84% | - | 44.98B | |
| +2.88% | +1.33% | +13.56% | +46.70% | +17.56% | +44.23% | +19.97% | -0.09% | +244.33% | 42.52B | |
| +1.01% | -3.79% | +15.23% | +31.63% | +19.01% | +8.89% | +76.51% | +8.57% | +1,126.06% | 40.78B | |
| -0.90% | -1.74% | -0.21% | +2.04% | +8.07% | +15.20% | +48.44% | -22.00% | +142.12% | 32.89B | |
| +2.07% | +6.09% | +9.06% | +22.58% | - | - | - | - | - | 17.09B | |
| +1.45% | -4.51% | +3.11% | +32.66% | +5.25% | +24.88% | +122.98% | +204.84% | +1,825.44% | 16.28B | |
| +1.70% | -0.05% | +7.44% | +18.65% | +16.63% | +18.53% | +28.09% | -40.97% | +96.09% | 14.4B | |
| +2.70% | -1.95% | +25.32% | +65.53% | +45.04% | +79.43% | +41.63% | -35.57% | +242.73% | 13.48B | |
| +0.50% | -4.21% | +2.15% | +17.65% | -11.20% | -9.01% | -37.44% | -38.07% | +109.76% | 12.45B | |
| -0.47% | -10.24% | +33.49% | +23.88% | +4.10% | -21.53% | - | - | - | 11.24B | |
| +0.26% | -0.01% | +0.33% | +45.42% | +23.07% | +35.48% | -6.32% | -43.32% | +170.86% | 11.32B | |
| -1.29% | -9.41% | +14.27% | +71.35% | +47.91% | +34.17% | +42.83% | -50.85% | - | 10.64B | |
| -1.83% | -3.74% | -9.93% | +53.17% | -19.73% | +40.07% | +447.90% | +200.16% | +2,353.05% | 10.68B | |
| -0.00% | +0.10% | +0.72% | +71.62% | +78.96% | +256.79% | +467.56% | - | - | 10.19B | |
| +2.14% | -3.60% | +12.09% | -16.29% | -22.79% | +6.24% | +55.26% | +50.63% | +107.33% | 9.95B | |
| +0.25% | -4.90% | +19.03% | +67.49% | +53.45% | +193.44% | +500.01% | +96.74% | - | 9.9B | |
| +0.35% | -6.29% | +15.75% | +37.02% | +19.98% | +686.87% | +1,525.84% | +12.26% | - | 9.87B | |
| -0.61% | -3.88% | +10.09% | +56.20% | +66.73% | +147.45% | +644.12% | +193.48% | +1,105.50% | 9.48B | |
| Average | +0.57% | -3.41% | +9.99% | +36.98% | +29.01% | +110.66% | +265.51% | +69.36% | +644.54% | 19.89B | |
| Weighted average by Cap. | +0.73% | -2.83% | +9.82% | +32.93% | +35.52% | +103.90% | +197.02% | +93.22% | +552.46% |
- Stock Market
- Stocks
- VRDN Stock
- Stock
- Sector Signal Genetics Inc
Select your edition
All financial news and data tailored to specific country editions
